Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea
Clinical and Experimental Dermatology · 2023
DOI: 10.1093/ced/llad028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2023. Verfasst von Hyun Kang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Dermatology, Yonsei University, Wonju College of Medicine, Wonju, Republic of Korea. Hauptthemen laut MEDLINE: Autoimmune Diseases, Vitiligo. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
The prevalence of vitiligo shows regional variance. Recently, an association between vitiligo and extracutaneous conditions including other autoimmune, metabolic and dermatological disorders has been suggested. Despite its increasing incidence, the epidemiological trends and comorbidities in people with vitiligo have rarely been quantified in Asia.
Aim
To determine the prevalence and incidence of vitiligo and the disorders associated with vitiligo using the National Health Insurance Service database.
Methods
We included all patients with vitiligo, classified by the International Classification of Disease, 10th revision (ICD-10) code of L80, with ≥ 3 documented visits from 2003 to 2019. The incidence and prevalence of vitiligo were estimated for the study period. Age-, sex-, insurance type- and income level-matched controls (ratio 1 : 5) were selected to compare comorbidities. The odds ratios between comorbidities and vitiligo were calculated through conditional logistic regression.
Results
The incidence and annual prevalence of vitiligo in Korea increased from 2003 to 2019, with incidence peaking in summer. Age-specific incidence showed a bimodal distribution, with the steepest increase in the group aged < 20 years. Many comorbidities, including alopecia areata, psoriasis, rheumatoid arthritis, systemic lupus erythematosus, Crohn disease, ulcerative colitis, Sjögren syndrome, diabetes mellitus, dyslipidaemia, chronic hepatitis, anxiety disorder and mood disorder showed higher odds ratios in patients with vitiligo than controls.
Conclusion
The incidence and prevalence of vitiligo are increasing, particularly among younger patients in Korea. In addition, various comorbidities are associated with vitiligo, therefore, if patients with vitiligo present with extracutaneous symptoms, physicians should consider the possibility of other comorbid diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Departments of Dermatology, Yonsei University, Wonju College of Medicine, Wonju, Republic of Korea.
- Preventive Medicine, Yonsei University, Wonju College of Medicine, Wonju, Republic of Korea.
ORCID-Profile: Hyun Kang
Zitieren
APA
Kang, H., & Lee, S. (2023). Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad028
Vancouver
Kang H, Lee S. Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea. Clinical and Experimental Dermatology. 2023. doi:10.1093/ced/llad028
BibTeX
@article{Kang2023,
author = {Kang, Hyun and Lee, Solam},
title = {Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea},
journal = {Clinical and Experimental Dermatology},
year = {2023},
doi = {10.1093/ced/llad028}
}
EUVIMED